Literature DB >> 26223324

Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak.

T Yan1, J Mu2, E Qin3, Y Wang4, L Liu5, D Wu3, H Jia6, Z Li7, T Guo8, X Wang9, Y Qin4, Y Li10, S Chen2, Y Zhang10, J Zhang10, Y Wu7, S Wang11, J Li12.   

Abstract

This article sought to analyze the clinical features of 154 patients suspected of having Ebola virus disease (EVD) in an Ebola holding center in Sierra Leone from October 1 through November 9, 2014. We found that 108 of the 154 patients were confirmed with EVD. Eighty-five had known outcomes. Forty-nine of the 85 patients had been exposed to EVD. The average mortality rate was 60%. The mean interval between the onset of symptoms and hospitalization was 5.8 ± 3.3 days. The mean incubation period was 9.2 ± 6.7 days. Common symptoms of the EVD patients on admission were fatigue (85.2%), anorexia (84.3%), fever (75.9%), and headache (72.2%). Our data showed that the total symptoms of confirmed EVD patients were significantly higher than those of non-EVD patients (9 vs. 5.5; p < 0.001). The likelihood of EVD was 87.6% when a patient presented more than 6 out of 21 symptoms on admission. The survivors were significantly younger than non-survivors (24.0 ± 10.0 years vs. 31.3 ± 15.3 years; p = 0.016). The real-time polymerase chain reaction (PCR) analysis showed that, in the survivors, the virus load was significantly lower (Ct value: 25.2 ± 4.1 vs. 28.7 ± 5.7; p = 0.002). Multivariate analysis showed that age, fever, and viral load were independent predictors of mortality. Taken together, our data suggested that a cutoff of six symptoms could be used to predict patients with high or low risk of EVD. It seemed that age, fever, and viral load were the main risk factors associated with EVD mortality.

Entities:  

Mesh:

Year:  2015        PMID: 26223324     DOI: 10.1007/s10096-015-2457-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   5.103


  15 in total

1.  Ebola therapy: Developing new drugs or repurposing old ones?

Authors:  Giovanni Lentini; Solomon Habtemariam
Journal:  Int J Cardiol       Date:  2014-11-11       Impact factor: 4.164

2.  Ebola virus disease in West Africa--clinical manifestations and management.

Authors:  Daniel S Chertow; Christian Kleine; Jeffrey K Edwards; Roberto Scaini; Ruggero Giuliani; Armand Sprecher
Journal:  N Engl J Med       Date:  2014-11-05       Impact factor: 91.245

Review 3.  Basic clinical and laboratory features of filoviral hemorrhagic fever.

Authors:  Mark G Kortepeter; Daniel G Bausch; Mike Bray
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

4.  Case fatality rate for Ebola virus disease in west Africa.

Authors:  Adam J Kucharski; W John Edmunds
Journal:  Lancet       Date:  2014-09-23       Impact factor: 79.321

5.  Could the devastation from Ebola occur in Asia?

Authors:  Dale Fisher; Sharon Salmon
Journal:  Ann Acad Med Singapore       Date:  2014-09       Impact factor: 2.473

6.  Clinical illness and outcomes in patients with Ebola in Sierra Leone.

Authors:  John S Schieffelin; Jeffrey G Shaffer; Augustine Goba; Michael Gbakie; Stephen K Gire; Andres Colubri; Rachel S G Sealfon; Lansana Kanneh; Alex Moigboi; Mambu Momoh; Mohammed Fullah; Lina M Moses; Bethany L Brown; Kristian G Andersen; Sarah Winnicki; Stephen F Schaffner; Daniel J Park; Nathan L Yozwiak; Pan-Pan Jiang; David Kargbo; Simbirie Jalloh; Mbalu Fonnie; Vandi Sinnah; Issa French; Alice Kovoma; Fatima K Kamara; Veronica Tucker; Edwin Konuwa; Josephine Sellu; Ibrahim Mustapha; Momoh Foday; Mohamed Yillah; Franklyn Kanneh; Sidiki Saffa; James L B Massally; Matt L Boisen; Luis M Branco; Mohamed A Vandi; Donald S Grant; Christian Happi; Sahr M Gevao; Thomas E Fletcher; Robert A Fowler; Daniel G Bausch; Pardis C Sabeti; S Humarr Khan; Robert F Garry
Journal:  N Engl J Med       Date:  2014-10-29       Impact factor: 91.245

7.  Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.

Authors:  M A Bwaka; M J Bonnet; P Calain; R Colebunders; A De Roo; Y Guimard; K R Katwiki; K Kibadi; M A Kipasa; K J Kuvula; B B Mapanda; M Massamba; K D Mupapa; J J Muyembe-Tamfum; E Ndaberey; C J Peters; P E Rollin; E Van den Enden; E Van den Enden
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

Review 8.  The ecology of Ebola virus.

Authors:  Allison Groseth; Heinz Feldmann; James E Strong
Journal:  Trends Microbiol       Date:  2007-08-15       Impact factor: 17.079

9.  Ethical and practical considerations in providing critical care to patients with Ebola virus disease.

Authors:  Parizad Torabi-Parizi; Richard T Davey; Anthony F Suffredini; Daniel S Chertow
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

10.  Fast vaccine offers hope in battle with Ebola.

Authors:  Tom Clarke; Jonathan Knight
Journal:  Nature       Date:  2003-08-07       Impact factor: 49.962

View more
  35 in total

1.  Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.

Authors:  Anita K McElroy; Jessica R Harmon; Timothy D Flietstra; Shelley Campbell; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Christopher J Kratochvil; Peter C Iwen; Philip W Smith; Rafi Ahmed; Stuart T Nichol; Christina F Spiropoulou
Journal:  Clin Infect Dis       Date:  2016-06-27       Impact factor: 9.079

Review 2.  Insights from clinical research completed during the west Africa Ebola virus disease epidemic.

Authors:  Amanda Rojek; Peter Horby; Jake Dunning
Journal:  Lancet Infect Dis       Date:  2017-04-28       Impact factor: 25.071

3.  Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea.

Authors:  Paul Loubet; Romain Palich; Richard Kojan; Olivier Peyrouset; Christine Danel; Sarala Nicholas; Mamoudou Conde; Klaudia Porten; Augustin Augier; Yazdan Yazdanpanah
Journal:  Am J Trop Med Hyg       Date:  2016-10-10       Impact factor: 2.345

4.  Prognostic and Predictive Factors of Ebola Virus Disease Outcome in Elderly People during the 2014 Outbreak in Guinea.

Authors:  Mahamoud Sama Cherif; Shyam Prakash Dumre; Diénaba Kassé; Fatoumata Cherif; Facely Camara; Alpha Koné; Mandiou Diakité; Mohamed Cissé; Mamadou Pathé Diallo; Edouard Le Gall; Juntra Karbwang; Kenji Hirayama
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

5.  The predictor of mortality outcome in adult patients with Ebola virus disease during the 2014-2015 outbreak in Guinea.

Authors:  M S Cherif; N Koonrungsesomboon; M P Diallo; E Le Gall; D Kassé; F Cherif; A Koné; M Diakité; F Camara; N Magassouba
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-25       Impact factor: 3.267

Review 6.  Ebola Infection in Pregnancy: A Global Perspective and Lessons Learned.

Authors:  Lisa B Haddad; John Horton; Bruce S Ribner; Denise J Jamieson
Journal:  Clin Obstet Gynecol       Date:  2018-03       Impact factor: 2.190

Review 7.  Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes.

Authors:  Lisa M Bebell; Titilope Oduyebo; Laura E Riley
Journal:  Birth Defects Res       Date:  2017-03-15       Impact factor: 2.344

Review 8.  Ebola vaccine R&D: Filling the knowledge gaps.

Authors:  Donata Medaglini; Ali M Harandi; Tom H M Ottenhoff; Claire-Anne Siegrist
Journal:  Sci Transl Med       Date:  2015-12-09       Impact factor: 17.956

9.  Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests.

Authors:  Maiken Worsøe Rosenstierne; Helen Karlberg; Karoline Bragstad; Gunnel Lindegren; Malin Lundahl Stoltz; Cristiano Salata; Anne-Marte Bakken Kran; Susanne Gjeruldsen Dudman; Ali Mirazimi; Anders Fomsgaard
Journal:  J Clin Microbiol       Date:  2016-07-27       Impact factor: 5.948

Review 10.  Neglected filoviruses.

Authors:  Robin Burk; Laura Bollinger; Joshua C Johnson; Jiro Wada; Sheli R Radoshitzky; Gustavo Palacios; Sina Bavari; Peter B Jahrling; Jens H Kuhn
Journal:  FEMS Microbiol Rev       Date:  2016-06-05       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.